Engineering Fellow and lead engineer in the development of HFOs, Barbara Minor, will be in Australia in early June, 2015.
As lead engineer in the development and commercialisation of HFOs at DuPont, Minor is a pioneer in refrigerant research and holds over 130 US patents.
During her career, she has led the development of several low GWP refrigerants for refrigeration and air conditioning applications, including Opteon YF for automotive air conditioning.
She was the lead engineer in the development and commercialization of Opteon XP10, 40 and 44 and is an active member of ASHRAE and AHRI where she chairs the AHRI Research and AHRTI Technology and Steering committees.
Minor has undertaken refrigerant research at DuPont for more than 25 years and is now a senior engineering fellow at the Chemours Company, a stand-alone company created by DuPont to manage its chemical operations including titanium technologies and fluoroproducts.
The Chemours Company is expected to begin trading as a public company in mid-2015 operating 37 production facilities located in 12 countries and serving thousands of customers in more than 130 countries.
With $7 billion in revenues and 9,100 employees, Chemours will be one of the largest chemical companies in the world.
Chemours business manager in Australia, John McCormack, said there are a few more challenges to deal with internally to finalise the new business locally but for sales staff it is business as usual.
“We are continuing to introduce new products and have completed registration of two of our HFO’s,” he said.
“As well as commencing commercial sales of Opteon YF (HFO1234YF), we have trials lined up for our Opteon XP40 and Opteon XP44.
“It is very exciting as we start a new company building on our 213 year history as we continue to innovate and show technology leadership.”